• Nie Znaleziono Wyników

ECG presentation of the LQT2 syndrome (HERG gene mutation)

N/A
N/A
Protected

Academic year: 2022

Share "ECG presentation of the LQT2 syndrome (HERG gene mutation)"

Copied!
1
0
0

Pełen tekst

(1)

343 www.fc.viamedica.pl

IMAGES IN CARDIOLOGY

Folia Cardiol.

2006, Vol. 13, No. 4, p. 343 Copyright © 2006 Via Medica ISSN 1507–4145

Address for correspondence: Wojciech Zaręba, MD, PhD Cardiology Division, University of Rochester

Medical Center

601 Elmwood Ave, Box 653, Rochester, NY 14642, USA e-mail: wojciech_zareba@urmc.rochester.edu

ECG presentation of the LQT2 syndrome (HERG gene mutation)

Wojciech Zaręba

Cardiology Division, University of Rochester Medical Center, Rochester, NY, USA

This is an ECG of a 28-year old woman with history of syncopal episodes and documented tor- sade de pointes ventricular tachycardia. First syn- copal episode occurred at age 16 during basket ball game. She has a positive history of sudden cardiac death.

ECG shows substantially prolonged QT (QTc between 0.46–0.66 s depending on lead) with pre- sence of flat and notched T wave. The T wave mor- phology is characteristic for the long QT syndrome

caused by the HERG gene mutation (LQT2), gene regulating function of the IKr delayed rectifier outward potassium current in myocardial cell. Pa- tients with LQT2 frequently have they cardiac events triggered by emotion, stress, or exercise.

Beta-blockers are standard of treatment in LQTS patients including LQT2, but they do not fully pro- tect high-risk patients who experience recurrent arrhythmic events. In such cases, an implantable cardioverter-defibrillator is considered.

Cytaty

Powiązane dokumenty

[22] A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC Clinical Trials

Poniżej przedstawiono zapis badania EKG 28-letniej kobiety z epizodami omdleń w wywiadzie oraz z udokumentowanymi incydentami częstoskur- czu komorowego torsade de pointes..

Najwyższy odsetek pozytywnych odpowiedzi na leczenie (CR + PR – 54,6%) oraz najniższy odsetek progresji choroby (PD - 9%) uzyskano w grupie, u której PLD zastosowano

also observed an association between Crohn’s disease and NOD2 3020insC gene mutation carrying in the group of 556 patients with colon cancer [18].. A significant relationship

Łącznie 100 pacjentów z cukrzycą typu 2, nadciśnieniem tętniczym, normo- lub mikro- albuminurią oraz nefropatią cukrzycową, w dwóch 50-osobowych grupach, przyjmowało telmisartan

Występowanie pierwszorzędowego złożonego punktu końcowego: zgon z przyczyn sercowo-na- czyniowych, zawał serca, udar mózgu lub hospitali- zacja z powodu zaostrzenia

Results: High HOMA2-IR defined as in fourth quartile (≥ 2.4) was associated with increased risk for recurrent coronary events (HR 1.44; CI 1.03–2.01; p = 0.03) after adjustment for

Up to date, five LQTS genes have been identi- fied, including the potassium channel gene HERG (LQT2) [3], which encodes the a-subunit of the channel that underlies the